Author

Keiji Nogami

Nara Medical University HospitalORCID 0000-0002-2415-2194Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Bioengineering· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Organism:mouse· 1 Organism:non-human primate· 1 Assay:protein sequence· 1

Frequent Co-Authors

Kio HorinakaiD· 1 shared Morisada HayakawaiD· 1 shared Nemekhbayar BaatartsogtiD· 1 shared Osamu NurekiiD· 1 shared Susumu UchiyamaiD· 1 shared Tiago J. S. LopesiD· 1 shared Tsukasa OhmoriiD· 1 shared Yuji KashiwakuraiD· 1 shared

Activity by Year

2025-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperBioengineering

Kio HorinakaORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Engineered coagulation factor VIII with enhanced secretion and coagulation potential for hemophilia A gene therapy

Yuji Kashiwakura, Yuto Nakajima, Kio Horinaka, Tiago J. S. Lopes, Yuma Furuta, Yuki Yamaguchi, Nemekhbayar Baatartsogt, Morisada Hayakawa, Yuko Katakai, Susumu Uchiyama, Osamu Nureki, Keiji Nogami, Tsukasa Ohmori

This paper develops engineered FVIII variants for hemophilia A gene therapy, showing improved secretion, coagulation activity, and efficacy at lower vector doses in mice and macaques.

Blood · Nov 7, 2025Peer-reviewedBioengineering